Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 178 of 1,261
  1. US 11725054

    Anti-CD83 antibodies and use thereof

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  2. US 11723635

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  3. CA 3235923

    PROCEDES DE SYNTHESE A GRANDE ECHELLE DE COMPLEXES DE RADIONUCLEIDES

    ADVANCED ACCELERATOR APPLICATIONS [FR] · Granted Aug 10, 2023 · Expires Aug 5, 2043

    granted
  4. US 11717573

    Methods and compositions for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  5. US 11718616

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  6. US 11718655

    Masked interleukin-12 polypeptides

    Xilio Development, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  7. US 11717547

    Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

    Krystal Biotech, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  8. US 11718612

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  9. US 11718665

    Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

    Rani Therapeutics, LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  10. US 11718530

    Allotrope of carbon having increased electron delocalization

    Structured Nano Carbon LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  11. US 11717553

    Combined plant extract for getting rid of mites and acne and preparation method and use thereof

    Nanjing Institute for Comprehensive Utilization of Wild Plants, All China Federation of Supply and Marketing Corporation · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  12. US 11718647

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  13. US 11718621

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  14. US 11718852

    Non-liposomal systems for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  15. US 11718834

    Compositions and methods for producing recombinant AAV

    Sangamo Therapeutics, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  16. US 11718679

    CD137 antibodies and PD-1 antagonists and uses thereof

    Compass Therapeutics LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  17. US 11718658

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  18. US 11718610

    Compounds containing benzosultam

    Medshine Discovery Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  19. US 11718613

    N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  20. US 11718630

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  21. US 11718641

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  22. US 11718618

    Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  23. US 11718591

    Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  24. US 11718589

    Compositions and methods of modulating short-chain dehydrogenase

    The Board of Regents of the University of Texas System · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.